We report for the first time that morphine-6-glucuronide, a highly analgesic morphine-derived molecule, is present in adrenal chromaffin granules and secreted from chromaffin cells upon stimulation. We also demonstrate that phosphatidylethanolamine-binding protein (alternatively named Raf-1 kinase inhibitor protein or RKIP) acts as an endogenous morphine-6-glucuronide-binding protein. An UDPglucuronosyltransferase 2B-like enzyme, described to transform morphine into morphine-6-glucuronide, has been immunodetected in the chromaffin granule matrix, and morphine-6-glucuronide de novo synthesis has been characterized, demonstrating the possible involvement of intragranular UDP-glucuronosyltransferase 2B-like enzyme in morphine-6-glucuronide metabolism. Once secreted into the circulation, morphine-6-glucuronide may mediate several systemic actions (e.g. on immune cells) based on its affinity for -opioid receptors. These activities could be facilitated by phosphatidylethanolamine-binding protein (PEBP), acting as a molecular shield and preventing morphine-6-glucuronide from rapid clearance. Taken together, our data represent an important observation on the role of morphine-6-glucuronide as a new endocrine factor.For 20 years, cerebral endogenous morphine has been isolated and characterized, and its structure has been shown to be identical to morphine from poppy (1, 2). In the 1990s, few groups succeeded in characterizing endogenous morphine from the organs and fluids of vertebrates, including bovine brain and adrenal gland, rat heart and adrenal gland, and human heart and urine (for review, Refs. 1-3); invertebrates (4 -6); and parasites (7,8). In mammals, the endogenous morphine synthetic pathway is associated with the dopamine and catecholamine biosynthetic pathway (for review, see Refs. 1, 3, and 9). Very recently, several crucial steps were reached when Zenk and co-workers (10, 11) demonstrated that morphine can be formed using a multistep biosynthetic route, and Zhu et al. (12) showed that human primary polymorphonuclear cells are able to synthesize morphine. These authors have shown morphine de novo synthesis in human and animal primary and cancer cell cultures.Chromaffin cells are neuroendocrine cells originating from the neural crest and are the predominant cell type in the adrenal medulla (for review, see Ref. 13). These cells possess the catecholamine biosynthetic pathway, leading to dopamine and adrenaline/noradrenaline synthesis (13). Chromaffin secretory granules contain a complex mixture of peptides and proteins that are co-released with catecholamines into the circulation in response to splanchnic nerve stimulation (13). Based on the morphine biosynthetic pathway and on the presence of morphine in bovine and rat adrenal glands (14, 15), rat pheochromocytoma PC-12 cells (10, 16), and eel chromaffin cells (17), we hypothesized that mammalian chromaffin cells might have the capacity to synthesize morphine and that their secretory granules could potentially release this alkaloid into the blood.Several mole...